Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis

N Engl J Med. 2017 Apr 27;376(17):1694. doi: 10.1056/NEJMc1702076.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting*
  • Recurrence